Cancer Immunotherapy and Nanobiotechnology: An Interdisciplinary Approach
暫譯: 癌症免疫療法與奈米生物技術：跨學科的探討
Rezaei, Nima
相關主題
商品描述
The "Cancer Immunotherapy and Nanobiotechnology: An Interdisciplinary Approach" is the twenty fifth volume of the "Interdisciplinary Cancer Research" series, publishes comprehensive volume on cancer immunotherapy and nanobiotechnology. The volume starts with chapters on targeting mitochondria in cancer immunotherapy, immunotherapy in oncology, and cancer treatments through immunological pathways. Immune checkpoint inhibitors as well as engineered iPSC-based strategies are explained in other chapters after discussion on cancer stem cells. CAR NK, CAR T cells, and DC therapy are the subjects of the following chapters. Then tumor microenviroment in response to immunotherapy and T-cell responses during cancer immunotherapy through the use of imaging are explained. The second half of the volume is focused on application of nanobiotechnology in cancer, starting with general chapters on nanotechnology for cancer research, nanotechnology and cancer therapy strategies, nanomedicine based cancer immunotherapy, applications of nanocarrier systems in cancer treatment, and nanoformulations in cancer theranostics. Then the role of metal nanomaterials in cancer therapy, synthetic drug nanodelivery systems, nanoparticles loaded with cytotoxic agents, nanocarrier-mediated drug delivery, vesicular nanosystem, and nanoscale metal-organic frameworks for cancer-targeted therapy are explained. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value for those who wish to have an update on cancer immunotherapy and nanobiotechnology.
商品描述(中文翻譯)
《癌症免疫療法與奈米生物技術：跨學科的探討》是《跨學科癌症研究》系列的第二十五卷，出版了有關癌症免疫療法和奈米生物技術的綜合性內容。本卷以針對癌症免疫療法中的線粒體、腫瘤學中的免疫療法以及通過免疫途徑的癌症治療為開端。隨後在討論癌症幹細胞後，解釋了免疫檢查點抑制劑以及基於工程化誘導多能幹細胞（iPSC）的策略。接下來的章節則探討了CAR NK、CAR T細胞和樹突細胞（DC）療法。然後，解釋了腫瘤微環境對免疫療法的反應以及在癌症免疫療法中利用影像技術的T細胞反應。本卷的後半部分專注於奈米生物技術在癌症中的應用，首先介紹了癌症研究的奈米技術、奈米技術與癌症治療策略、基於奈米醫學的癌症免疫療法、奈米載體系統在癌症治療中的應用，以及癌症治療診斷中的奈米配方。接著，解釋了金屬奈米材料在癌症治療中的角色、合成藥物奈米傳遞系統、載有細胞毒性劑的奈米顆粒、奈米載體介導的藥物傳遞、囊泡奈米系統，以及用於癌症靶向治療的奈米級金屬有機框架。這是癌症免疫學計畫（CIP）的主要概念，該計畫是全球科學教育與研究網絡（USERN）的一部分。本書對於希望了解癌症免疫療法和奈米生物技術最新進展的讀者將具有特別的價值。
作者簡介
Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than two hundred research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He has edited more than one hundred international books, has presented more than a thousand lectures/posters in congresses/meetings, and has published more than 1,700 scientific papers in the international journals.
作者簡介(中文翻譯)
教授尼瑪·雷扎伊（Nima Rezaei）於德黑蘭醫科大學獲得醫學學位（MD），隨後在英國謝菲爾德大學獲得分子與遺傳醫學碩士學位（MSc）及臨床免疫學與人類遺傳學博士學位（PhD）。他還在紐卡斯爾綜合醫院完成了兒科臨床免疫學和骨髓移植的短期研究獎學金。雷扎伊教授目前是德黑蘭醫科大學免疫學的全職教授及研究與技術副院長，並且是免疫缺陷研究中心的共同創辦人及負責人。他也是全球科學教育與研究網絡（USERN）的創始人。雷扎伊教授已經擔任超過兩百個研究項目的主任，並設計及參與多個國際合作項目。雷扎伊教授是超過五十本國際期刊的編輯、編輯助理或編輯委員會成員。他編輯了超過一百本國際書籍，在會議/研討會上發表了超過一千場演講/海報，並在國際期刊上發表了超過1,700篇科學論文。
